Citizens Jmp Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Posted by George Bondi on Jul 22nd, 2026

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) had its price objective raised by analysts at Citizens Jmp from $23.00 to $25.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “market outperform” rating on the real estate investment trust’s stock. Citizens Jmp’s price objective would suggest a potential upside of 14.03% from the company’s previous close.

Several other equities analysts also recently weighed in on the company. Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Raymond James Financial assumed coverage on Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating for the company. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $22.08.

Read Our Latest Stock Report on SBRA

Sabra Healthcare REIT Trading Down 0.5%

SBRA traded down $0.12 during trading on Wednesday, hitting $21.93. The company’s stock had a trading volume of 1,708,514 shares, compared to its average volume of 2,765,608. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.55. The stock has a market cap of $5.53 billion, a PE ratio of 34.85, a PEG ratio of 1.49 and a beta of 0.65. The firm’s 50 day moving average price is $19.61 and its 200-day moving average price is $19.78. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The business had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business’s revenue was up 20.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts expect that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Sabra Healthcare REIT by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after acquiring an additional 481,231 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Nuveen LLC grew its holdings in shares of Sabra Healthcare REIT by 28.6% during the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after purchasing an additional 1,625,072 shares during the period. Geode Capital Management LLC increased its position in Sabra Healthcare REIT by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after purchasing an additional 198,118 shares in the last quarter. Finally, Bank of America Corp DE increased its position in Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after purchasing an additional 447,528 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.